|
2024
|
Invention
|
Compositions and methods for reducing complement activation.
Compositions and methods for reduci... |
|
|
Invention
|
Modified regulatory t cells and methods of using the same.
The disclosure features modified regu... |
|
|
Invention
|
Identification of nanoparticles for preferential tissue or cell targeting.
Provided herein inclu... |
|
|
Invention
|
Hemoglobin g-makassar binding polypeptides and antibodies and methods of using the same.
Describ... |
|
|
Invention
|
Novel rna base editing compositions, systems, methods and uses thereof.
The present invention pr... |
|
|
Invention
|
Compositions and methods for altering a nucleobase in a lipoprotein(a) polynucleotide. LPALPALPA ... |
|
|
Invention
|
Compositions and methods for base editing a phenylalanine hydroxylase polynucleotide. PAHPAHPAH p... |
|
|
Invention
|
Methods of substituting pathogenic amino acids using programmable base editor systems.
Provided ... |
|
|
Invention
|
Interferon inhibition with viral proteins and fragments and fusions thereof. Provided herein is a... |
|
|
Invention
|
Prime editing of single base mutations in sickle cell disease. HBB HBB gene with prime editing. |
|
|
Invention
|
Cd5-binding polypeptides, compositions comprising the same, and methods for use thereof. in vivoi... |
|
|
Invention
|
Ionizable lipids with branched head groups. The present disclosure describes compositions, prepar... |
|
|
Invention
|
Ionizable lipids with linear head groups. The present disclosure describes compositions, preparat... |
|
|
Invention
|
Modified immune effector cells with improved resistance to natural killer cell-mediated allorejec... |
|
|
Invention
|
Anti-idiotypic antibodies to cluster of differentiation 7-targeted binding domains and related co... |
|
|
Invention
|
Nanomaterials.
The present disclosure describes compositions, preparations, nanoparticles (such ... |
|
|
Invention
|
Nanomaterials comprising tetravalent lipid compounds.
The present disclosure describes compositi... |
|
|
Invention
|
Nanomaterials comprising diamines.
The present disclosure describes compositions, preparations, ... |
|
|
Invention
|
Ionizable amine and ester lipids and lipid nanoparticles.
The present disclosure describes compo... |
|
|
Invention
|
Ionizable amine lipids and lipid nanoparticles.
The present disclosure describes compositions, p... |
|
|
Invention
|
Nanomaterials comprising disulfides.
The present disclosure describes compositions, preparations... |
|
|
Invention
|
Methods and compositions for treating alpha-1 antitrypsin deficiency. Compositions and methods fo... |
|
|
Invention
|
Compositions and methods for the treatment of spinal muscular atrophy (sma).
The invention of th... |
|
|
Invention
|
Crispr enzymes, methods, systems and uses thereof.
The present invention provides novel systems,... |
|
|
Invention
|
Modified immune cells and methods of using the same.
The present invention features modified imm... |
|
|
Invention
|
Methods and compositions for anti-cd45 based non-genotoxic conditioning. The disclosure compositi... |
|
|
Invention
|
Compositions and methods for the treatment of hereditary angioedema (hae).
The invention of the ... |
|
|
Invention
|
Compositions and methods for treating stargardt disease. ABCA4ABCA4ABCA4 gene so that the nucleot... |
|
|
Invention
|
Modified guide rna. The present invention relates to modified gRNA molecules, compositions and me... |
|
|
Invention
|
Genetic modification of hepatocytes.
The present invention provides methods of producing genetic... |
|
|
Invention
|
Compositions and methods for treating hepatitis b virus infection.
The invention features compos... |
|
|
Invention
|
Immunosuppressant-resistant modified allogeneic modified immune cells and methods for use thereof... |
|
|
Invention
|
Nanomaterials comprising triols.
The present disclosure describes compositions, preparations, na... |
|
|
Invention
|
Modified immune effector cells with improved efficacy. Multiplex base edited chimeric antigen rec... |
|
|
Invention
|
Persistent allogeneic modified immune cells and methods of use thereof.
The present disclosure f... |
|
|
Invention
|
Chimeric pseudotyped recombinant rabies virus.
Provided herein are chimeric pseudotyped recombin... |
|
|
Invention
|
Chimeric pseudotyped recombinant rabies virus. Provided herein are chimeric pseudotyped recombina... |
|
|
Invention
|
Guide rnas for crispr/cas editing systems.
The present invention provides, among other things, a... |
|
2023
|
Invention
|
Circular guide rnas for crispr/cas editing systems.
The present invention provides, among other ... |
|
|
Invention
|
Compositions and methods for the self-inactivation of base editors.
The invention features polyn... |
|
|
Invention
|
Compositions and methods for editing a transthyretin gene. Compositions for gene modification rel... |
|
|
Invention
|
Base editing of transthyretin gene.
Provided herein are compositions for gene modification relat... |
|
|
Invention
|
Compositions and methods for treating transthyretin amyloidosis.
The invention features composit... |
|
|
Invention
|
Base editing of transthyretin gene. Provided herein are compositions for gene modification relate... |
|
|
Invention
|
Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target seq... |
|
|
P/S
|
Pharmaceutical and biological preparations based on base editing, base modification, nucleobase e... |
|
|
Invention
|
Adenosine deaminase variants and uses thereof.
The invention provides adenosine deaminase varian... |
|
|
Invention
|
Synthetic polypeptides and uses thereof. Provided herein are synthetic polypeptides including tra... |
|
|
Invention
|
Uses of adenosine base editors.
The disclosure provides methods and compositions for treating bl... |
|
|
Invention
|
Nanomaterials comprising an ionizable lipid.
The present disclosure describes compositions, prep... |
|
2022
|
Invention
|
Novel crispr enzymes, methods, systems and uses thereof.
The present invention provides novel sy... |
|
2019
|
P/S
|
Pharmaceutical and biological preparations based on base
correction, base editing, base modifica... |
|
|
P/S
|
Scientific and medical research in the fields of base editing, base modification, base repair, nu... |
